GGrantIndex
← Leaderboards

Allison Deborah Fryer

Oregon Health & Science University

$11,207,409
Attributed
$17,390,251
Total exposure
9
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,390,251 · 9

By mechanism

R01$11,283,288 · 6
TL1$5,796,639 · 1
P01$305,324 · 1
R13$5,000 · 1

Top collaborators

Most similar at Oregon Health & Science University

Same institution · by research overlap

Others in their field

Top investigators on “Neurons

Research focus

NeuronsAsthmaEosinophilLungAirway HyperresponsivenessAcetylcholineMediatingNerveBronchoconstrictionResponseReceptor ExpressionFunctional DisorderAnimalsReceptor FunctionOzoneIn VivoPathway InteractionsMuscarinic M2 ReceptorPhysiologicalExposure ToPrevalenceInflammationCell Adhesion MoleculesAntigens

Grant awards (40)

Mechanisms of tachykinergic nerve-mediated severe bronchoconstriction and inflammation$775,634
R01 · FY2025 · HL
NRSA Training Core$696,735
TL1 · FY2025 · TR · contact PI
Insulin increases nerve-mediated bronchoconstriction in obesity-related asthma$611,559
R01 · FY2025 · HL
Mechanisms of tachykinergic nerve-mediated severe bronchoconstriction and inflammation$769,599
R01 · FY2024 · HL
Insulin increases nerve-mediated bronchoconstriction in obesity-related asthma$601,846
R01 · FY2024 · HL
NRSA Training Core$519,594
TL1 · FY2024 · TR · contact PI
NRSA Training Core$818,349
TL1 · FY2023 · TR · contact PI
Insulin increases nerve-mediated bronchoconstriction in obesity-related asthma$630,545
R01 · FY2023 · HL
NRSA Training Core$800,473
TL1 · FY2022 · TR · contact PI
Oregon Clinical and Translational Research Institute TL1 Program$629,295
TL1 · FY2021 · TR
Oregon Clinical and Translational Research Institute TL1 Program$644,538
TL1 · FY2020 · TR
Insulin Modulates Parasympathetic Nerve Control of Lungs$473,022
R01 · FY2020 · HL · contact PI
Oregon Clinical and Translational Research Institute TL1 Program$624,744
TL1 · FY2019 · TR
Insulin Modulates Parasympathetic Nerve Control of Lungs$459,752
R01 · FY2019 · HL · contact PI
Oregon Clinical and Translational Research Institute TL1 Program$542,532
TL1 · FY2018 · TR
Insulin Modulates Parasympathetic Nerve Control of Lungs$464,129
R01 · FY2018 · HL · contact PI
Oregon Clinical and Translational Research Institute TL1 Program$520,379
TL1 · FY2017 · TR
Insulin Modulates Parasympathetic Nerve Control of Lungs$462,524
R01 · FY2017 · HL · contact PI
Role of macrophages in organophosphorus pesticide-induced airway hyperreactivity$339,605
R01 · FY2014 · ES
Role of macrophages in organophosphorus pesticide-induced airway hyperreactivity$336,175
R01 · FY2013 · ES
Role of macrophages in organophosphorus pesticide-induced airway hyperreactivity$342,943
R01 · FY2012 · ES
Role of macrophages in organophosphorus pesticide-induced airway hyperreactivity$342,386
R01 · FY2011 · ES
Asthma Exacerbation by Organophosphate Pesticides$332,812
R01 · FY2011 · ES · contact PI
Role of macrophages in organophosphorus pesticide-induced airway hyperreactivity$358,625
R01 · FY2010 · ES
Asthma Exacerbation by Organophosphate Pesticides$336,174
R01 · FY2010 · ES · contact PI
Asthma Exacerbation by Organophosphate Pesticides$339,570
R01 · FY2009 · ES · contact PI
Asthma Exacerbation by Organophosphate Pesticides$339,570
R01 · FY2008 · ES · contact PI
Ozone inhibition of Neuronal m2 receptor function$328,545
R01 · FY2008 · HL · contact PI
Recent Advances in Muscarinic Receptor Pharmacology and Therapeutics.$5,000
R13 · FY2008 · GM · contact PI
Asthma Exacerbation by Organophosphate Pesticides$345,844
R01 · FY2007 · ES · contact PI
Ozone inhibition of Neuronal m2 receptor function$328,545
R01 · FY2007 · HL · contact PI
Ozone inhibition of Neuronal m2 receptor function$337,259
R01 · FY2006 · HL · contact PI
Ozone inhibition of Neuronal m2 receptor function$343,125
R01 · FY2005 · HL
OZONE INHIBITION OF NEURONAL M2 MUSCARINIC RECEPTORS$302,000
R01 · FY2004 · HL
OZONE INHIBITION OF NEURONAL M2 MUSCARINIC RECEPTORS$327,000
R01 · FY2003 · HL
OZONE INHIBITION OF NEURONAL M2 MUSCARINIC RECEPTORS$327,000
R01 · FY2002 · HL
MECHANISMS OF HYPERREACTIVITY IN ATOPIC HOSTS$0
P01 · FY2002 · HL
OZONE INHIBITION OF NEURONAL M2 MUSCARINIC RECEPTORS$327,500
R01 · FY2001 · HL
MECHANISMS OF HYPERREACTIVITY IN ATOPIC HOSTS$0
P01 · FY2001 · HL
MECHANISMS OF HYPERREACTIVITY IN ATOPIC HOSTS$305,324
P01 · FY2000 · HL